Adaptive Biotechnologies Corp (ADPT) CEO and Chairman Chad M Robins Sold $2 million of Shares

Author's Avatar
Aug 01, 2020
Article's Main Image

CEO and Chairman of Adaptive Biotechnologies Corp (30-Year Financial, Insider Trades) Chad M Robins (insider trades) sold 54,028 shares of ADPT on 07/31/2020 at an average price of $37.74 a share. The total sale was $2 million.

Adaptive Biotechnologies Corp has a market cap of $4.79 billion; its shares were traded at around $37.32 with and P/S ratio of 16.69. GuruFocus has detected 1 severe warning sign with Adaptive Biotechnologies Corp. .

CEO Recent Trades:

  • CEO and Chairman Chad M Robins sold 54,028 shares of ADPT stock on 07/31/2020 at the average price of $37.74. The price of the stock has decreased by 1.11% since.

CFO Recent Trades:

  • CFO Chad M Cohen sold 30,000 shares of ADPT stock on 07/08/2020 at the average price of $46.87. The price of the stock has decreased by 20.38% since.

Directors and Officers Recent Trades:

  • SVP and General Counsel Stacy L Taylor sold 2,880 shares of ADPT stock on 07/24/2020 at the average price of $36.03. The price of the stock has increased by 3.58% since.
  • Chief Business Development Off Sharon Benzeno sold 417 shares of ADPT stock on 07/20/2020 at the average price of $40. The price of the stock has decreased by 6.7% since.
  • David E. Goel sold 2,000,000 shares of ADPT stock on 07/20/2020 at the average price of $40. The price of the stock has decreased by 6.7% since.
  • Chief Scientific Officer Harlan S Robins sold 33,300 shares of ADPT stock on 07/17/2020 at the average price of $39.58. The price of the stock has decreased by 5.71% since.
  • Chief People Officer Francis Lo sold 2,000 shares of ADPT stock on 07/15/2020 at the average price of $43.86. The price of the stock has decreased by 14.91% since.

For the complete insider trading history of ADPT, click here

.